The role of large gene deletions and duplications in MYBPC3 and TNNT2 in patients with hypertrophic cardiomyopathy
- PMID: 19666196
- DOI: 10.1016/j.ijcard.2009.07.009
The role of large gene deletions and duplications in MYBPC3 and TNNT2 in patients with hypertrophic cardiomyopathy
Abstract
Hypertrophic cardiomyopathy (HCM) is the most common cardiovascular genetic disorder, and can result in heart failure and sudden death in the young. No mutation is identified in up to 50% of cases of HCM following comprehensive analysis of known causal genes, however standard methods overlook large deletions and duplications. The multiple ligation-dependent probe amplification method was used to screen for large deletions and duplications in the myosin-binding protein-C (MYBPC3) and cardiac troponin T (TNNT2) genes in patients with HCM. One novel 3 base pair deletion was identified in MYBPC3 in a severely affected patient; however this change was also found in an unaffected relative. No alterations in the TNNT2 gene were identified. In conclusion, large deletions and duplications do not appear to play a major role in the pathogenesis of HCM.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.J Cardiovasc Med (Hagerstown). 2006 Aug;7(8):601-7. doi: 10.2459/01.JCM.0000237908.26377.d6. J Cardiovasc Med (Hagerstown). 2006. PMID: 16858239
-
Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.Rev Port Cardiol. 2011 Jan;30(1):7-18. Rev Port Cardiol. 2011. PMID: 21425739
-
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.J Am Coll Cardiol. 2004 Nov 2;44(9):1903-10. doi: 10.1016/j.jacc.2004.07.045. J Am Coll Cardiol. 2004. PMID: 15519027
-
[Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].Invest Clin. 2004 Mar;45(1):69-99. Invest Clin. 2004. PMID: 15058760 Review. Spanish.
-
[Genetic changes and clinical management in familial hypertrophic cardiomyopathy].Wiad Lek. 2000;53(1-2):4-21. Wiad Lek. 2000. PMID: 10806915 Review. Polish.
Cited by
-
Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy.PLoS One. 2017 Aug 3;12(8):e0181465. doi: 10.1371/journal.pone.0181465. eCollection 2017. PLoS One. 2017. PMID: 28771489 Free PMC article.
-
Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.Expert Rev Mol Diagn. 2010 Apr;10(3):329-51. doi: 10.1586/erm.10.13. Expert Rev Mol Diagn. 2010. PMID: 20370590 Free PMC article. Review.
-
Dilated Cardiomyopathy: A Genetic Journey from Past to Future.Int J Mol Sci. 2024 Oct 25;25(21):11460. doi: 10.3390/ijms252111460. Int J Mol Sci. 2024. PMID: 39519012 Free PMC article. Review.
-
Practical Aspects in Genetic Testing for Cardiomyopathies and Channelopathies.Clin Biochem Rev. 2019 Nov;40(4):187-200. doi: 10.33176/AACB-19-00030. Clin Biochem Rev. 2019. PMID: 31857740 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous